This invention relates to medical apparatus and procedures in general, and more particularly to medical apparatus and procedures for reconstructing a ligament.
Ligaments are tough bands of tissue which serve to connect the articular extremities of bones, and/or to support and/or retain organs in place within the body. Ligaments are typically made up of coarse bundles of dense fibrous tissue which are disposed in a parallel or closely interlaced manner, with the fibrous tissue being pliant and flexible but not significantly extensible.
In many cases, ligaments are torn or ruptured as the result of an accident. Accordingly, various procedures have been developed to repair or replace such damaged ligaments.
For example, in the human knee, the anterior and posterior cruciate ligaments (i.e., the “ACL” and “PCL”) extend between the top end of the tibia and the bottom end of the femur. The ACL and PCL serve, together with other ligaments and soft tissue, to provide both static and dynamic stability to the knee. Often, the anterior cruciate ligament (i.e., the ACL) is ruptured or torn as the result of, for example, a sports-related injury. Consequently, various surgical procedures have been developed for reconstructing the ACL so as to restore substantially normal function to the knee.
In many instances, the ACL may be reconstructed by replacing the ruptured ACL with a graft ligament. More particularly, in such a procedure, bone tunnels are generally formed in both the top of the tibia and the bottom of the femur, with one end of the graft ligament being positioned in the femoral tunnel and the other end of the graft ligament being positioned in the tibial tunnel, and with the intermediate portion of the graft ligament spanning the distance between the bottom of the femur and the top of the tibia. The two ends of the graft ligament are anchored in their respective bone tunnels in various ways well known in the art so that the graft ligament extends between the bottom end of the femur and the top end of the tibia in substantially the same way, and with substantially the same function, as the original ACL. This graft ligament then cooperates with the surrounding anatomical structures so as to restore substantially normal function to the knee.
In some circumstances, the graft ligament may be a ligament or tendon which is harvested from elsewhere within the patient's body, e.g., a patella tendon with or without bone blocks attached, a semitendinosus tendon and/or a gracilis tendon. In other circumstances, the graft ligament may be harvested from a cadaver. In still other circumstances, the graft ligament may be a synthetic device. For the purposes of the present invention, all of the foregoing may be collectively referred to herein as a “graft ligament”.
As noted above, various approaches are well known in the art for anchoring the two ends of the graft ligament in the femoral and tibial bone tunnels.
In one well-known procedure, which may be applied to femoral fixation, tibial fixation, or both, the end of the graft ligament is placed in the bone tunnel, and then the graft ligament is fixed in place using a headless orthopedic screw, generally known in the art as an “interference” screw. More particularly, with this approach, the end of the graft ligament is placed in the bone tunnel and then the interference screw is advanced into the bone tunnel so that the interference screw extends parallel to the bone tunnel and simultaneously engages both the graft ligament and the side wall of the bone tunnel. In this arrangement, the interference screw essentially drives the graft ligament laterally, into engagement with the opposing side wall of the bone tunnel, whereby to secure the graft ligament to the host bone with a so-called “interference fit”. Thereafter, over time (e.g., several months), the graft ligament and the host bone grow together at their points of contact so as to provide a strong, natural joinder between the ligament and the bone.
Interference screws have proven to be an effective means for securing a graft ligament in a bone tunnel. However, the interference screw itself generally takes up a substantial amount of space within the bone tunnel, which can limit the surface area contact established between the graft ligament and the side wall of the bone tunnel. This in turn limits the region of bone-to-ligament in-growth, and hence can affect the strength of the joinder. By way of example but not limitation, it has been estimated that the typical interference screw obstructs about 50% of the potential bone-to-ligament integration region.
For this reason, substantial efforts have been made to provide interference screws fabricated from absorbable materials, so that the interference screw can eventually disappear over time and bone-to-ligament in-growth can take place about the entire perimeter of the bone tunnel. To this end, various absorbable interference screws have been developed which are made from biocompatible, bioabsorbable polymers, e.g., polylactic acid (PLA), polyglycolic acid (PGA), etc. These polymers generally provide the substantial mechanical strength needed to advance the interference screw into position, and to thereafter hold the graft ligament in position while bone-to-ligament in-growth occurs, without remaining in position on a permanent basis.
In general, interference screws made from such biocompatible, bioabsorbable polymers have proven clinically successful. However, these absorbable interference screws still suffer from several disadvantages. First, clinical evidence suggests that the quality of the bone-to-ligament in-growth is somewhat different than natural bone-to-ligament in-growth, in the sense that the aforementioned bioabsorbable polymers tend to be replaced by a fibrous mass rather than a well-ordered tissue matrix. Second, clinical evidence suggests that absorption generally takes a substantial period of time, e.g., on the order of three years or so. Thus, during this absorption time, the bone-to-ligament in-growth is still significantly limited by the presence of the interference screw. Third, clinical evidence suggests that, for many patients, absorption is never complete, leaving a substantial foreign mass remaining within the body. This problem is exacerbated somewhat by the fact that absorbable interference screws generally tend to be fairly large in order to provide them with adequate strength, e.g., it is common for an interference screw to have a diameter (i.e., an outer diameter) of 8-12 mm and a length of 20-25 mm.
Thus, there is a need for a new and improved interference fixation system which (i) has the strength needed to hold the graft ligament in position while bone-to-ligament in-growth occurs, and (ii) promotes superior bone-to-ligament in-growth.
These and other objects are addressed by the provision and use of a novel helicoil interference fixation system for attaching a graft ligament to a bone.
In one preferred form of the invention, there is provided a novel helicoil interference fixation system comprising:
a helicoil comprising a helical body comprising a plurality of turns separated by spaces therebetween, the helical body terminating in a proximal end and a distal end, and at least one internal strut extending between at least two turns of the helical body; and
an inserter for turning the helicoil, the inserter comprising at least one groove for receiving the at least one strut;
the helicoil being mounted on the inserter such that the at least one strut of the helicoil is mounted in the at least one groove of the inserter, such that rotation of the inserter causes rotation of the helicoil.
In another preferred form of the invention, there is provided a novel method for attaching a graft ligament to a bone, the method comprising:
In another preferred form of the invention, there is provided a novel helicoil comprising a helical body comprising a plurality of turns separated by spaces therebetween, the helical body terminating in a proximal end and a distal end, and at least one internal strut extending between at least two turns of the helical body, wherein the at least one internal strut comprises a helical construction.
These and other objects and features of the present invention will be more fully disclosed or rendered obvious by the following detailed description of the preferred embodiments of the invention, which is to be considered together with the accompanying drawings wherein like numbers refer to like parts, and further wherein:
The present invention comprises the provision and use of a novel helicoil interference fixation system for attaching a graft ligament to a bone or other tissue.
For convenience, the present invention will hereinafter be discussed in the context of its use for an ACL tibial and/or femoral fixation; however, it should be appreciated that the present invention may also be used for the fixation of other graft ligaments to the tibia and/or the femur; and/or the fixation of other graft ligaments to other bones or to other tissue such as organs.
Looking first at
More particularly, and looking now at
One or more struts 45 are disposed within the interior of helical body 20, with the one or more struts 45 being secured to the interior surfaces 50 of helical body 20. The one or more struts 45 provide a means for turning helicoil 10 during deployment within the body, as will hereinafter be discussed in further detail. In addition, the one or more struts 45 can provide structural support for the turns 40 of helical body 20. The one or more struts 45 may be formed integral with helical body 20 (e.g., by a molding process), or they may be formed separately from helical body 20 and then attached to helical body 20 in a separate manufacturing process (e.g., by welding). Where the one or more struts 45 are formed integral with helical body 20, the one or more struts 45 can be used to help flow melt into position.
In one preferred form of the invention, the one or more struts 45 comprise helical structures. And in one particularly preferred form of the invention, the one or more struts 45 comprise helical structures which spiral in the opposite direction from the spiral of helical body 20, and the one or more struts 45 have a pitch which is substantially greater than the pitch of helical body 20. See
Preferably, the number of struts 45, and their size, are selected so as to close off an insignificant portion of the spaces or gaps 35 between the turns 40 of helical body 20, whereby to substantially not impede the passage of fluids and tissue through the helicoil. At the same time, however, the number of struts 45, their size, and composition, are selected so as to provide an adequate means for turning helicoil 10 during deployment, and to provide any necessary support for the turns 40 of helical body 20.
In one preferred form of the present invention, one strut 45 is provided.
In another preferred form of the present invention, a plurality of struts 45 (e.g., two, three, four or more struts) are provided.
And in one preferred form of the present invention, the struts 45 collectively close off less than fifty percent (50%) of the spaces or gaps 35 between the turns 40 of helical body 20.
And in one particularly preferred form of the present invention, the struts 45 collectively close off less than twenty percent (20%) of the spaces or gaps 35 between the turns 40 of helical body 20.
Helicoil 10 is formed out of one or more biocompatible materials. These biocompatible materials may be non-absorbable (e.g., stainless steel or plastic) or absorbable (e.g., a bioabsorbable polymer). In one preferred form of the present invention, helicoil 10 preferably comprises a bioabsorbable polymer such as polylactic acid (PLA), polyglycolic acid (PGA), etc. In any case, however, helicoil 10 comprises a material which is capable of providing the strength needed to set the fixation device into position and to hold the graft ligament in position while bone-to-ligament in-growth occurs.
Inserter 15 is shown in
It should be appreciated that tapered seat-forming thread 75 is matched to helicoil 10 so that when helicoil 10 is mounted on inserter 15, tapered seat-forming thread 75 provides the proper lead-in for helicoil 10.
Preferably, interior surfaces 50 of helical body 20 and distal end 60 of inserter 15 are tapered, expanding outwardly in the proximal direction, so that helicoil 10 and inserter 15 form a positive seat such that the interior surface of the helicoil is in direct contact with the tapered body diameter of the inserter.
Thus it will be seen that, when helicoil 10 is mounted on the distal end of shaft 55, inserter 15 may be used to advance the helicoil to a surgical site and, via rotation of handle 80, turn helicoil 10 into the gap between a graft ligament and the wall of a bone tunnel, whereby to create an interference fixation of the graft ligament in the bone tunnel. Significantly, inasmuch as inserter 15 has a tapered seat-forming thread 75 formed on its distal end in advance of helicoil 10, the tapered seat-forming thread can form a seat into the tissue in advance of helicoil 10, whereby to permit the helicoil to advance easily into the tissue and create the desired interference fixation. Accordingly, helicoil 10 does not need to have any penetrating point on its distal end in order to penetrate the tissue.
If desired, inserter 15 may be cannulated so that the inserter and helicoil 10 may be deployed over a guidewire, as will hereinafter be discussed.
Helicoil interference fixation system 5 may be utilized in a manner generally similar to that of a conventional interference screw system in order to attach a graft ligament to a bone.
More particularly, and looking now at
Thereafter, and looking now at
If desired, helicoil interference fixation system 5 can then be used in a similar manner to form a tibial fixation. See
Significantly, forming the fixation device in the form of an open helical coil has proven particularly advantageous, inasmuch as the open helical coil provides the strength needed to set the fixation device into position, and hold the graft ligament in position while bone-to-ligament in-growth occurs, while still providing extraordinary access through the body of the fixation device. Thus, cell- and nutrient-bearing fluids can move substantially unimpeded through the body of helicoil 10, and tissue in-growth can occur across the body of helicoil 10.
Furthermore, it has been found that when the graft ligament thereafter imposes axial loads on the interference fit, struts 45 help maintain the structural integrity of turns 40 of helical body 20, whereby to ensure the integrity of the interference fit.
In
In
Furthermore, as seen in
It should also be appreciated that an interference fit may be formed using a plurality of helicoils 10. Thus, as seen in
If desired, and looking now at
As seen in
Additionally, if desired, helicoil 10 can be tapered between its distal end 25 and its proximal end 30.
It will be appreciated that still further embodiments of the present invention will be apparent to those skilled in the art in view of the present disclosure. It is to be understood that the present invention is by no means limited to the particular constructions and method steps herein disclosed and/or shown in the drawings, but also comprises any modifications or equivalents within the scope of the invention.
This patent application is a continuation of pending U.S. patent application Ser. No. 12/392,804, filed Feb. 25, 2009, which claims the benefit of U.S. Provisional Application Ser. No. 61/200,285 filed Nov. 26, 2008; and is a continuation-in-part of abandoned U.S. patent application Ser. No. 11/893,440, filed Aug. 16, 2007, which claims the benefit of U.S. Provisional Application Ser. No. 60/838,119 filed Aug. 16, 2006. Each patent application identified above is incorporated by reference in its entirety herein.
Number | Name | Date | Kind |
---|---|---|---|
3499222 | Linkow et al. | Mar 1970 | A |
3869942 | DeCaro | Mar 1975 | A |
4177797 | Baylis et al. | Dec 1979 | A |
4653489 | Tronzo | Mar 1987 | A |
4741651 | Despres | May 1988 | A |
4834757 | Brantigan | May 1989 | A |
4854311 | Steffee | Aug 1989 | A |
4913143 | Oloff et al. | Apr 1990 | A |
4961740 | Ray et al. | Oct 1990 | A |
5026373 | Ray et al. | Jun 1991 | A |
5055104 | Ray | Oct 1991 | A |
5116337 | Johnson | May 1992 | A |
5129904 | Illi | Jul 1992 | A |
5129906 | Ross et al. | Jul 1992 | A |
5197967 | Wilson | Mar 1993 | A |
5236431 | Gogolewski et al. | Aug 1993 | A |
5242447 | Borzone | Sep 1993 | A |
5354299 | Coleman | Oct 1994 | A |
5364400 | Rego, Jr. et al. | Nov 1994 | A |
5383878 | Roger et al. | Jan 1995 | A |
5407427 | Zhu et al. | Apr 1995 | A |
5411523 | Goble | May 1995 | A |
5447533 | Vachon et al. | Sep 1995 | A |
5464427 | Curtis et al. | Nov 1995 | A |
5470334 | Ross et al. | Nov 1995 | A |
5531780 | Vachon | Jul 1996 | A |
5571139 | Jenkins, Jr. | Nov 1996 | A |
5593409 | Michelson | Jan 1997 | A |
5609635 | Michelson | Mar 1997 | A |
5626613 | Schmieding | May 1997 | A |
5645547 | Coleman | Jul 1997 | A |
5658285 | Marnay et al. | Aug 1997 | A |
5676545 | Jones | Oct 1997 | A |
5681352 | Clancy, III et al. | Oct 1997 | A |
5688285 | Yamada | Nov 1997 | A |
5695497 | Stahelin | Dec 1997 | A |
5709683 | Bagby | Jan 1998 | A |
5802794 | Robson | Sep 1998 | A |
5833715 | Vachon et al. | Nov 1998 | A |
5888227 | Cottle | Mar 1999 | A |
5891146 | Simon et al. | Apr 1999 | A |
5921982 | Lesh et al. | Jul 1999 | A |
5951560 | Simon et al. | Sep 1999 | A |
5961524 | Crombie | Oct 1999 | A |
5964783 | Grafton et al. | Oct 1999 | A |
5968047 | Reed | Oct 1999 | A |
5968098 | Winslow | Oct 1999 | A |
5984967 | Zdeblick et al. | Nov 1999 | A |
6008433 | Stone | Dec 1999 | A |
6039762 | McKay | Mar 2000 | A |
6086593 | Bonutti | Jul 2000 | A |
6096060 | Fitts et al. | Aug 2000 | A |
6097986 | Janke et al. | Aug 2000 | A |
6196780 | Wakai et al. | Mar 2001 | B1 |
6235057 | Roger et al. | May 2001 | B1 |
6283973 | Hubbard et al. | Sep 2001 | B1 |
6360129 | Ley et al. | Mar 2002 | B1 |
6443989 | Jackson | Sep 2002 | B1 |
6447545 | Bagby | Sep 2002 | B1 |
6488683 | Lieberman | Dec 2002 | B2 |
6514257 | Dovesi et al. | Feb 2003 | B2 |
6517542 | Papay et al. | Feb 2003 | B1 |
6527774 | Lieberman | Mar 2003 | B2 |
6544265 | Lieberman | Apr 2003 | B2 |
6551319 | Lieberman | Apr 2003 | B2 |
6551320 | Lieberman | Apr 2003 | B2 |
6551322 | Lieberman | Apr 2003 | B1 |
6554830 | Chappius | Apr 2003 | B1 |
6589245 | Weiler et al. | Jul 2003 | B1 |
6626917 | Craig | Sep 2003 | B1 |
6823871 | Schmieding | Nov 2004 | B2 |
6855168 | Crozet | Feb 2005 | B2 |
6863671 | Strobel et al. | Mar 2005 | B1 |
6953462 | Lieberman | Oct 2005 | B2 |
7033372 | Cahalan | Apr 2006 | B1 |
7070586 | Hart et al. | Jul 2006 | B2 |
7083647 | Sklar et al. | Aug 2006 | B1 |
7189251 | Kay | Mar 2007 | B2 |
7195634 | Schmieding et al. | Mar 2007 | B2 |
7217279 | Reese | May 2007 | B2 |
7322986 | Wolf | Jan 2008 | B2 |
7594929 | Collette | Sep 2009 | B2 |
7608098 | Stone et al. | Oct 2009 | B1 |
7867252 | Criscuolo et al. | Jan 2011 | B2 |
7914539 | Stone et al. | Mar 2011 | B2 |
8016865 | Donnelly et al. | Sep 2011 | B2 |
8034090 | Stone et al. | Oct 2011 | B2 |
8636799 | Sklar et al. | Jan 2014 | B2 |
20020022862 | Grafton et al. | Feb 2002 | A1 |
20020055737 | Lieberman | May 2002 | A1 |
20020055738 | Lieberman | May 2002 | A1 |
20020055742 | Lieberman | May 2002 | A1 |
20020087189 | Bonutti | Jul 2002 | A1 |
20020087190 | Benavitz et al. | Jul 2002 | A1 |
20020099382 | Salazar et al. | Jul 2002 | A1 |
20020143335 | von Hoffmann et al. | Oct 2002 | A1 |
20020165546 | Goble et al. | Nov 2002 | A1 |
20030055431 | Brannon | Mar 2003 | A1 |
20030065374 | Honeck | Apr 2003 | A1 |
20030069640 | Ferreira et al. | Apr 2003 | A1 |
20030125749 | Yuan et al. | Jul 2003 | A1 |
20030181913 | Lieberman | Sep 2003 | A1 |
20040015170 | Tallarida et al. | Jan 2004 | A1 |
20040030343 | Kurc | Feb 2004 | A1 |
20040039404 | Dreyfuss | Feb 2004 | A1 |
20040073216 | Lieberman | Apr 2004 | A1 |
20040097945 | Wolf | May 2004 | A1 |
20040122424 | Ferree | Jun 2004 | A1 |
20040143158 | Hart et al. | Jul 2004 | A1 |
20040143237 | Hart et al. | Jul 2004 | A1 |
20040153074 | Bojarski et al. | Aug 2004 | A1 |
20040267265 | Kyle | Dec 2004 | A1 |
20050107828 | Reese | May 2005 | A1 |
20050159727 | Lesh | Jul 2005 | A1 |
20050222681 | Richley et al. | Oct 2005 | A1 |
20050234458 | Huebner | Oct 2005 | A1 |
20050250984 | Lam et al. | Nov 2005 | A1 |
20050250985 | Saadat et al. | Nov 2005 | A1 |
20050250987 | Ewers et al. | Nov 2005 | A1 |
20050250988 | Ewers et al. | Nov 2005 | A1 |
20050283239 | Crozet | Dec 2005 | A1 |
20060009769 | Lieberman | Jan 2006 | A1 |
20060030948 | Manrique et al. | Feb 2006 | A1 |
20060079895 | McLeer | Apr 2006 | A1 |
20060100627 | Stone et al. | May 2006 | A1 |
20060106390 | Jensen et al. | May 2006 | A1 |
20060142769 | Collette | Jun 2006 | A1 |
20060149266 | Cordasco | Jul 2006 | A1 |
20060217681 | Hart et al. | Sep 2006 | A1 |
20060241636 | Novak et al. | Oct 2006 | A1 |
20060247642 | Stone et al. | Nov 2006 | A1 |
20060253080 | Tulleken et al. | Nov 2006 | A1 |
20060276841 | Barbieri et al. | Dec 2006 | A1 |
20070032797 | Ortiz et al. | Feb 2007 | A1 |
20070093895 | Donnelly et al. | Apr 2007 | A1 |
20070122764 | Balfour et al. | May 2007 | A1 |
20070142849 | Ewers et al. | Jun 2007 | A1 |
20070185532 | Stone et al. | Aug 2007 | A1 |
20070198019 | Schomer et al. | Aug 2007 | A1 |
20080027446 | Stone et al. | Jan 2008 | A1 |
20080065114 | Stone et al. | Mar 2008 | A1 |
20080082128 | Stone | Apr 2008 | A1 |
20080132932 | Hoeppner et al. | Jun 2008 | A1 |
20080140092 | Stone et al. | Jun 2008 | A1 |
20080140093 | Stone et al. | Jun 2008 | A1 |
20080154314 | McDevitt | Jun 2008 | A1 |
20080179839 | Walters | Jul 2008 | A1 |
20090024174 | Stark | Jan 2009 | A1 |
20090042951 | Danziger | Feb 2009 | A1 |
20090076544 | DiMatteo et al. | Mar 2009 | A1 |
20090248029 | Paulos | Oct 2009 | A1 |
20090319043 | McDevitt et al. | Dec 2009 | A1 |
20100106166 | Cropper et al. | Apr 2010 | A1 |
20110112576 | Nguyen et al. | May 2011 | A1 |
20110224727 | Housman et al. | Sep 2011 | A1 |
20110282450 | Donnelly et al. | Nov 2011 | A1 |
20110319933 | Tepic | Dec 2011 | A1 |
20130150859 | Kehres et al. | Jun 2013 | A1 |
20130158596 | Miller et al. | Jun 2013 | A1 |
20130158597 | Hernandez | Jun 2013 | A1 |
20130158598 | Lizardi | Jun 2013 | A1 |
20130158599 | Hester et al. | Jun 2013 | A1 |
20130158610 | Hernandez | Jun 2013 | A1 |
20140142697 | Sklar et al. | May 2014 | A1 |
Number | Date | Country |
---|---|---|
1829479 | Sep 2006 | CN |
101031248 | Sep 2007 | CN |
0538895 | Apr 1993 | EP |
0669110 | Aug 1995 | EP |
0682917 | Nov 1995 | EP |
1093774 | Apr 2001 | EP |
1147751 | Oct 2001 | EP |
2601894 | Jun 2013 | EP |
2760355 | Sep 1998 | FR |
2803739 | Jul 2001 | FR |
2846867 | May 2004 | FR |
9608205 | Mar 1996 | WO |
9619947 | Jul 1996 | WO |
9802117 | Jan 1998 | WO |
9826717 | Jun 1998 | WO |
2006055516 | May 2006 | WO |
2007093192 | Aug 2007 | WO |
WO2008021474 | Feb 2008 | WO |
2008100944 | Aug 2008 | WO |
2009042951 | Apr 2009 | WO |
Entry |
---|
Hunt, Patrick, D.V.M. et al. “Development of a Perforated Biodegradable Interference Screw” , Arthroscopy: The Journal of Arthroscopic and Related Surgery, vol. 21, No. 3, Mar. 2005; pp. 258-265. |
International Search and Written Opinion for PCT/US2011/027837 mailed May 19, 2011. |
Smith & Nephew brochure titled “Bio RCITM Bioabsorbable Screws: Anatomically Targeted Screws for ACL and PCL Reconstruction”, 2000. |
Biomet brochure “Bio-CoreTM Interference Screw”, 2007. |
International Search and Written Opinion for PCT/US2009/065304 mailed Jun. 5, 2013. |
International Search and Written Opinion for PCT/US2012/041298 mailed Jun. 5, 2013. |
International Search and Written Opinion for PCT/US2012/028803 mailed Oct. 24, 2010. |
Notice of Reasons for Rejections for Japanese Patent Application No. 2011-538642, mailed Oct. 1, 2013. |
First Office Action for Chinese Patent Application No. 200980155954.7, issued Apr. 12, 2013. |
Second Office Action for Chinese Patent Application No. 200980155954.7, issued Oct. 24, 2013. |
Number | Date | Country | |
---|---|---|---|
20130325125 A1 | Dec 2013 | US |
Number | Date | Country | |
---|---|---|---|
61200285 | Nov 2008 | US | |
60838119 | Aug 2006 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 12392804 | Feb 2009 | US |
Child | 13962580 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 11893440 | Aug 2007 | US |
Child | 12392804 | US |